欢迎来到 Jackson中国区代理商/公司/官网
全国咨询热线： 17754422825
产品中心 免疫学产品 分子生化产品 细胞生物学产品 植物学产品
联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话：18771149750

传真：15172469628

邮箱：sales@amyjet.com

新闻中心
ScreenFect-Logo_neu_21_2c08d653e1ee60d55cd0da551026ea56.png

艾美捷科技代理Screenfect品牌全系列产品

ScreenFect GmbH成立于2012年，是一家专注于细胞转染技术创新的德国生物技术公司。ScreenFect®转染试剂是该公司的核心产品，是依托组合化学方法构建独特化学文库，通过高通量细胞筛选平台高效开发的转染试剂。ScreenFect®转染试剂适用于多种核酸分子（包括pDNA、siRNA、mRNA、miRNA）的单转染与共转染，在难转染细胞（如原代细胞、干细胞）中具有优异性能。


Screenfect页面.png


▎ScreenFect®转染试剂

● ScreenFect®A是一款通用型转染试剂，适用于pDNA、siRNA、mRNA的递送以及共转染实验，可广泛应用于多种细胞系（如HEK、HeLa、MEF）及部分原代细胞系。高效转染：在96孔板中仅需低于100ng DNA即可实现高转染效率。

● ScreenFect®siRN 是转染小干扰RNA双链体的理想选择，适用于HEK、HeLa、MEF等标准哺乳动物细胞系及多种原代细胞系。

● ScreenFect®mRNA是专为mRNA转染优化的高效试剂。

● ScreenFect®A-plus是一款多功能增强型转染试剂，适用于pDNA、siRNA、mRNA的转染及共转染实验，在几乎所有细胞系（包括难转染细胞）中均能实现高效转染。


货号品名规格Dilution buffer
S-3001ScreenFect®A1 mL50 mL
S-3001-2ScreenFect®A0,2 mL10 mL
S-4001ScreenFect®siRNA1 mL50 mL
S-4001-2ScreenFect®siRNA0,2 mL10 mL
S-5001ScreenFect®mRNA1 mL50 mL
S-5001-2ScreenFect®mRNA0,2 mL10 mL
S-6001ScreenFect®A-plus1 mL50 mL
S-6001-2ScreenFect®A-plus0,2 mL10 mL
S-2001-2ScreenFect Buffer10 mL-
S-2001ScreenFect Buffer50 mL-


ScreenFect®转染试剂具有以下特点：

● 低细胞毒性：显著降低对细胞活性的影响

● 省时一步法：支持细胞铺板与转染同步操作（即用型方案）

● 快速优化：针对新用户/新细胞系提供简易优化流程

● 血清兼容性：无需更换培养基，可直接在含血清环境下使用

● 无动物源成分：杜绝动物源性物质污染风险

● 高通量适用：完美适配大规模筛选实验需求


▎ScreenFect®UP-293

ScreenFect®UP-293 是一款专为高效生产抗体及蛋白设计的转染试剂，适用于HEK 293-F悬浮细胞体系。配合ScreenFect®Booster增效剂使用，可最大化提升悬浮细胞中的蛋白产量。


产品编号悬浮培养体积组分组分体积
S-8010-0.5L0.5 litreScreenFect®UP-2931 mL
ScreenFect®Booster2.5 mL
ScreenFect®Buffer35 mL
S-8010-1L1 litreScreenFect®UP-2932 mL
ScreenFect®Booster5 mL
ScreenFect®Buffer70 mL
S-8010-10L10 litresScreenFect®UP-29320 mL
ScreenFect®Booster50 mL
ScreenFect®Buffer700 mL
S-8010-50L50 litresScreenFect®UP-293100 mL
ScreenFect®Booster250 mL
ScreenFect®Buffer3.5 L
<

▎ScreenFect®Booster

在完成HEK293F悬浮细胞的ScreenFect®UP-293转染后，于转染后16小时添加ScreenFect®Booster增效剂，可显著提升蛋白产量。该增效剂含特定复合组分，通过重编程细胞代谢路径（从增殖模式转向蛋白合成模式），从而高效提升大多数目标蛋白的表达水平。


货号品名规格
S-2001-2ScreenFect Buffer10 mL
S-2001ScreenFect Buffer50 mL


" data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Screenfect品牌全系列产品"> 艾美捷科技代理Screenfect品牌全系列产品
...
阅读详情
65ab095e3a4b3.png

艾美捷科技代理SeraCare对照及参比物质。

艾美捷科技有限公司，自2018年与SeraCare（现隶属于LGC Clinical Diagnostics）合作以来，长期为中国客户提供包括SeraSeq系列参比物质，领域包括肿瘤、生殖健康和遗传病。SeraCare研发和生产一系列临床参比物质，可以用于任何研发阶段，以确保临床基因组学检测结果的准确性。

 

SeraCare参比物质涵盖的范围：

1）Next Generation Sequencing

2）Sanger Sequencing

3）Real-time PCR and digital PCR (dPCR)

4）Microarray

 

主要特点

1）Ready-to-use reference materials covering clinically-relevant variants and all variant types - SNVs, INDELS, CNVs, and RNA fusions

2）Highly multiplexed - provide significantly more data per NGS run, saving sequencing costs

3）Available in multiple formats to suite different workflow needs - purified DNA & RNA, ctDNA, encapsulated ctDNA in plasma, and FFPE

4）Manufactured in cGMP-compliant, ISO 13485-certified facilities

5）Stringent product release testing - all variants qualified by dPCR for allele frequencies or copy numbers

 

参比物质货号规格
Seraseq® Whole Transcriptome RNA Seq Mix0710-21291 x 20 µl
Seraseq® Unmethylated ctDNA Mutation Mix0710-30881 x 25 µl
Seraseq® Tumor Mutation DNA Mix v2 AF 7 HC0710-00951 x 25 µl
Seraseq® Tumor Mutation DNA Mix v2 AF 10 HC0710-00941 x 25 µl
Seraseq® Tri-Level Tumor Mutation DNA Mix v2 HC0710-00971 x 25 µl
Seraseq® TNA (DNA/RNA) WT Mix0710-15802 x 20 µl
Seraseq® Solid Tumor CNV Mix, +6 copies0710-28671 x 20 µl
Seraseq® Solid Tumor CNV Mix, +3 copies0710-28661 x 20 µl
Seraseq® Solid Tumor CNV Mix, +12 copies0710-28681 x 20 µl
Seraseq® NTRK Fusion RNA Mix0710-16961 x 20 µl
Seraseq® Myeloid Mutation DNA Mix0710-04081 x 25 µl
Seraseq® Myeloid Fusion RNA Mix0710-04071 x 25 µl
Seraseq Myeloid ctDNA Mix WT0710-26461 x 25 µl
Seraseq Myeloid ctDNA Mix AF1%0710-26491 x 25 µl
Seraseq Myeloid ctDNA Mix AF0.5%0710-26481 x 25 µl
Seraseq Myeloid ctDNA Mix AF0.1%0710-26471 x 25 µl
Seraseq® MSI Reference Panel Mix AF5%0710-16752 x 15 µl
Seraseq® MSI Reference Panel Mix AF20%0710-16762 x 15 µl
Seraseq® Methylated ctDNA Mutation Mix0710-30891 x 25 µl
Seraseq® Lymphoma DNA Mutation Mix0710-22031 x 25 µl
Seraseq™ Lung & Brain CNV Mix, + 6 copies0710-04151 x 20 µl
Seraseq® Lung & Brain CNV Mix, + 3 copies0710-04141 x 20 µl
Seraseq® Lung & Brain CNV Mix, + 12 copies0710-04161 x 20 µl
Seraseq® HRD gDNA Negative Mix0710-28812 x 20 µl
Seraseq® HRD gDNA Low-Positive Mix0710-28802 x 20 µl
Seraseq® HRD gDNA High-Positive Mix0710-28792 x 20 µl
Seraseq® gDNA TMB Reference Panel Mix0710-24635 x 20 µl
Seraseq® gDNA TMB Mix Score 90710-13252 x 500 ng
Seraseq® gDNA TMB Mix Score 70710-13262 x 500 ng
Seraseq® gDNA TMB Mix Score 260710-13232 x 500 ng
Seraseq® gDNA TMB Mix Score 200710-13242 x 500 ng
Seraseq® gDNA TMB Mix Score 130710-15862 x 10 µl
Seraseq® gDNA MSI-High Mix0710-16701 x 20 µl
Seraseq® gDNA BRCA1/2 LGR Somatic Mutation Mix0730-05671 x 25 µl
Seraseq® gDNA BRCA1/2 LGR Inherited Mutation Mix0730-05681 x 25 µl
Seraseq® Fusion RNA Mix v40710-04971 x 25 µl
Seraseq® FFPE WT (DNA/RNA) Reference Material0710-01371 x 10 µm
Seraseq® FFPE TMB RM Score 90710-13082 x 10 µm
Seraseq® FFPE TMB RM Score 70710-13102 x 10 µm
Seraseq® FFPE TMB RM Score 260710-13072 x 10 µm
Seraseq® FFPE TMB RM Score 200710-13092 x 10 µm
Seraseq® FFPE TMB RM Score 130710-16182 x 10 um
Seraseq® FFPE Solid Tumor CNV Reference Materials0710-28651 x 10 µm
Seraseq® FFPE NTRK Fusion RNA Reference Material0710-10311 x 10 µm
Seraseq® FFPE MSI-High RM0710-22361 x 10 um
Seraseq® FFPE Lymphoma DNA Reference Material0710-22021 x 10 µm
Seraseq® FFPE HRD Negative RM0710-26441 x 10 µm
Seraseq® FFPE HRD Low-Positive RM0710-26451 x 10 µm
Seraseq® FFPE HRD High-Positive RM0710-26431 x 10 µm
Seraseq® FFPE Tumor Fusion RNA v4 Reference Material0710-04961 x 10 µm
Seraseq® FFPE BRCA1/2 LGR Reference Material0730-05641 x 10 µm
Seraseq® ctDNA Reference Material v2 WT0710-02081 x 5 mL
Seraseq® ctDNA Reference Material v2 AF2%0710-02031 x 5 mL
Seraseq® ctDNA Reference Material v2 AF1%0710-02041 x 5 mL
Seraseq® ctDNA Reference Material v2 AF0.5%0710-02051 x 5 mL
Seraseq® ctDNA Reference Material v2 AF0.125%0710-02071 x 5 mL
Seraseq® ctDNA Mutation Mix v2 WT0710-01441 x 25 µl
Seraseq® ctDNA Mutation Mix v2 AF2%0710-01391 x 25 µl
Seraseq® ctDNA Mutation Mix v2 AF1%0710-01401 x 25 µl
Seraseq® ctDNA Mutation Mix v2 AF0.5%0710-01411 x 25 µl
Seraseq® ctDNA Mutation Mix v2 AF0.25%0710-01421 x 25 µl
Seraseq® ctDNA Mutation Mix v2 AF0.125%0710-01431 x 25 µl
Seraseq® ctDNA MRD Panel Mix0710-21464 x 20 µl
Seraseq® ctDNA Complete™ Reference Material WT (0%)0710-06741 x 5 mL
Seraseq® ctDNA Complete™ Reference Material AF5%0710-06691 x 5 mL
Seraseq® ctDNA Complete™ Reference Material AF2.5%0710-06701 x 5 mL
Seraseq® ctDNA Complete™ Reference Material AF1%0710-06711 x 5 mL
Seraseq® ctDNA Complete™ Reference Material AF0.5%0710-06721 x 5 mL
Seraseq® ctDNA Complete™ Reference Material AF0.1%0710-06731 x 5 mL
Seraseq® ctDNA Complete™ Mutation Mix WT (0%)0710-05331 x 25 µl
Seraseq® ctDNA Complete™ Mutation Mix AF5%0710-05281 x 25 µl
Seraseq® ctDNA Complete™ Mutation Mix AF2.5%0710-05291 x 25 µl
Seraseq® ctDNA Complete™ Mutation Mix AF1%0710-05301 x 25 µl
Seraseq® ctDNA Complete™ Mutation Mix AF0.5%0710-05311 x 25 µl
Seraseq® ctDNA Complete™ Mutation Mix AF0.1%0710-05321 x 25 µl
Seraseq® Compromised FFPE WT (DNA/RNA) RM0710-17101 x 10 µm
Seraseq® Compromised FFPE Tumor DNA RM0710-14921 x 10 µm
Seraseq® Breast CNV Mix, + 6 copies0710-04121 x 20 µl
Seraseq® Breast CNV Mix, + 3 copies0710-04111 x 20 µl
Seraseq® Breast CNV Mix, + 12 copies0710-04131 x 20 µl
Seraseq® Blood TMB Mix Score 70710-20873 x 20 µl
Seraseq® Blood TMB Mix Score 260710-20903 x 20 µl
Seraseq® Blood TMB Mix Score 200710-20893 x 20 µl
Seraseq® Blood TMB Mix Score 130710-20883 x 20 µl
Seraseq® Turner Syndrome (XO) Reference Material0720-09521 x 1 mL
Seraseq® Trisomy 21 Male-Matched Reference Material0720-01671 x 1 mL
Seraseq® Trisomy 21 Female-Matched Reference Material0720-01681 x 1 mL
Seraseq® Trisomy 18 Male-Matched Reference Material0720-01711 x 1 mL
Seraseq® Trisomy 18 Female-Matched Reference Material0720-01721 x 1 mL
Seraseq® Trisomy 13 Male-Matched Reference Material0720-07791 x 1 mL
Seraseq® Trisomy 13 Female-Matched Reference Material0720-07801 x 1 mL
Seraseq® Triple X Syndrome (XXX) Reference Material0720-10691 x 1 mL
Seraseq® PGT-A Trisomy 21 Reference Material0720-07751 x 10 µl
Seraseq® PGT-A Trisomy 18 Reference Material0720-07761 x 10 µl
Seraseq® PGT-A Trisomy 13 Reference Material0720-07771 x 10 µl
Seraseq® PGT-A Euploid Reference Material0720-07781 x 10 µl
Seraseq® Klinefelter Syndrome (XXY) Reference Material0720-09531 x 1 mL
Seraseq® Jacobs Syndrome (XYY) Reference Material0720-09541 x 1 mL
Seraseq® Euploid Male-Matched Reference Material0720-01691 x 1 mL
Seraseq® Euploid Female-Matched Reference Material0720-01701 x 1 mL
Seraseq® 22q11 Male-Matched Reference Material0720-01731 x 1 mL
Seraseq® 22q11 Female-Matched Reference Material0720-01741 x 1 mL
Seraseq® Inherited Cancer DNA Mix v10730-00031 x 200 µL
Seraseq® gDNA BRCA1/2 LGR Inherited Mutation Mix0730-05681 x 25 µL
Seraseq® FFPE BRCA1/2 LGR Reference Material0730-05641 x 10 µm
Seraseq® Cardiomyopathy Reference Material0740-00211 x 200 µL
< " data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理SeraCare对照及参比物质"> 艾美捷科技代理SeraCare对照及参比物质
...
阅读详情
R&D Systems.jpg

R&D Systems位于美国的明尼苏达州，一直致力于生物制品的开发与生产。公司成立之初主要生产用于医院及临床应用的血控品。1977年，公司推出第一个产品--富血小板血浆质控品；1981年，公司成为全球第二家生产含血小板全血控品的供应商。40多年的发展中，R&D Systems仍持续开发各种血控品产品。

 

1985年，作为公司推出的第一个科研试剂产品，也是全球第一家将该产品进行商业化生产的产品，R&D Systems成功上市了TGF-beta1蛋白。作为胞外信号分子，TGF-beta1蛋白在多种细胞中进行表达，并作为胞外信号分子参与免疫功能，细胞增殖和细胞分化等生物学过程。该产品推出后，公司陆续从生物材料中纯化了几种细胞因子产品并推向市场。天然蛋白类产品的成功推广，加速了R&D Systems在细胞因子市场的开拓。公司于1985年形成Growth Factor事业部（现Biotechnology事业部）。Biotechnology事业部的目标是生产和营销重组人细胞因子。与天然来源提取蛋白相比较，DNA重组技术生产的蛋白产品其成本更低，产量更高，完全摆脱原料的限制。1989年，Biotechnology事业部开始开发抗细胞因子的单克隆和多克隆抗体，并于1990年开发了第一个ELISA试剂盒。

 

R&D System的主要产品包括：

Recombinant Proteins

GMP Proteins

Antibodies

ELISAs

Luminex Assays & High Performance Assays

Stem Cell Products

Cell Culture

Small Molecules & Peptides

Enzymes

ELISpots

cDNA Clones

Flow Cytometry Workflow Solutions

Proteome Profiler Antibody Arrays

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="R&D System"> R&D System
...
阅读详情
Immundiagnostik AG.png

Immunodiagnostik公司（德国）主要开发,生产和销售常规或科研用的体外诊断试剂和免疫化学产品。该公司专门研究临床实验诊断和医疗研究不同领域的创新免疫测定及其它分析方法（例如HPLC）。Immunodiagnostik的产品远销30多个国家，并与许多科研组织建立了合作关系，共同参与研究。公司通过和制药企业、学术界的协作，成功地开发出各种产品。

 

Immundiagnostik AG, founded in 1986, is a globally operating diagnostics company represented in over 70 countries. We focus on the development and production of innovative immunoassays and other analytical detection methods (e.g. HPLC and PCR) for medical routine and research. Furthermore, we offer a broad portfolio of antibodies and antigens.

 

Immundiagnostik offers a broad product and service portfolio in various clinical areas:

Cardiovascular and renal diseases

Skeletal system

Gastroenterology

Anti-Aging / Oxidative Stress

 

Immundiagnostik AG的主要产品包括：

Skeletal System

Fertility

Gastroenterology / Nutrition

Cardiovascular and Renal Systems

HPLC, LC-MS/MS

Clinical Immunology

Complementary Medicine

Molecular Biology

Oncology

Antigens

Antibodies

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Immundiagnostik AG"> Immundiagnostik AG
...
阅读详情
Reliatech.jpg

ReliaTech全称为受体配体技术有限公司 (Receptor Ligand Technologies GmbH)位于德国不伦瑞克，是一家后基因组生物技术公司。公司运用独特技术专注于受体和配体的发现与研究。除其他研究试剂，ReliaTech也开发应用于血管与淋巴管生成研究的相关高品质试剂。产品主要包括重组蛋白(细胞因子、生长因子、可溶性受体)、抗体、ELISA试剂盒等。

 

ReliaTech GmbH (short for Receptor Ligand Technologies GmbH) is a post-genomic German biotechnology company founded in 1999. Besides other research products the company develops, produces and sells high quality research reagents for angiogenic and lymphangiogenic research.

 

As a company with own in-house reagent production ReliaTech GmbH also offers solutions for customer specific reagent production. Our profound experiences in protein purification and our practical knowledge in daily laboratory business also flow into our customer based projects - making us a competent partner for projects requiring individual production solutions.

 

Reliatech的主要产品包括：

Recombinant Proteins

Antibodies

ELISA Kits

Specialities

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Reliatech"> Reliatech
...
阅读详情
ViroStat.jpg

ViroStat于1985年，由Douglas McAllister博士创立，致力于为研究者和工业界提供传染性疾病的抗体产品。产品线涵盖病毒学、细菌学和寄生虫学，应用于呼吸道药、性病药、胃肠药/毒素和食源性致病菌的检测。ViroStat拥有超过500种传染性疾病相关的试剂，其中包括MONOTOPE系列单克隆抗体、PMNITOPE多克隆抗体和数量众多的重组蛋白抗原。基于长期的经验积累，ViroStat能够提供从100ug到10g级别的产品。

 

ViroStat was founded in 1985 by Dr. Douglas McAllister to provide infectious disease antibody tools to researchers and manufacturers. These include the areas of virology, bacteriology and parasitology. Applications for these include detection of respiratory agents, STD agents, gastrointestinal agents/toxins and food borne pathogens.

 

The company offers more than 500 infectious disease reagents including their MONOTOPE™ monoclonal antibodies, OMNITOPE™ polyclonal antibodies and numerous recombinant antigens. Many of these antibodies are used by manufacturers of rapid, point of care tests currently made and sold in the US.

 

ViroStat公司产品包括：

MONOTOPE™ - Monoclonal Antibodies (Mouse) 小鼠单克隆抗体

RABMAB® - Monoclonal Antibodies (Rabbit) 兔单克隆抗体

OMNITOPE™ - Polyclonal Antibodies多克隆抗体

RECOMBINANT ANTIGENS 重组抗原

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ViroStat"> ViroStat
...
阅读详情
Diversified Biotech.png

Diversified Biotech是一家专门从事实验室常用耗材、仪器的生产商，其产品包括：用于冻存容器的标签、高粘度标签、冻存相关产品、特殊标签、组织培养相关产品、PCR相关产品、液体操作相关产品、电泳相关产品等。

 

主要产品类型：

Cryo-Tags® & Tough-Spots®

Tough-Tags®

Cryogenic/Freezer Storage

Specialty Labels

Label Accessories

Tissue Culture

PCR

Liquid Handling

Lab Essentials

Tube Racks/Storage

Equipment

Sample Cooling

Electrophoresis

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com


" data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Diversified Biotech"> Diversified Biotech
...
阅读详情
Molecular Innovations.jpg

Molecular Innovations公司为全球的研究人员提供高质量的科研产品，包括纤溶酶原激活物抑制因子1，肾素，肾素原，玻连蛋白，纤维蛋白，纤维连接蛋白，血纤维蛋白溶酶原，血纤维蛋白溶酶，抗凝血酶，ELISA试剂盒，抗体和其他研究使用的试剂。

 

Molecular Innovations, founded in 1990, is a primary manufacturer of research antibodies, proteins and ELISA kits. We specialize in coagulation and thrombolysis reagents including PAI-1, tPA, urokinase, clotting factors, vitronectin, fibrinogen, fibronectin, clotting factors, prorenin/renin, albumin, and immunoglobulins. Our customers all over the world include pharmaceutical and biotechnology companies as well as major research institutions. We offer custom projects and bulk quotes. All products are manufactured under stringent quality control standards at our new state of the art facility in Novi, MI, USA.

 

Molecular innovations的主要产品包括：

Research Models

Molecular Biology

Purified Proteins

Elisa Kits

Monoclonal Antibodies

Polyclonal Antibodies

Inhibitors And Substrates

Chromatography Resins

Plasmas And Tissues

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com


" data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Molecular Innovations"> Molecular Innovations
...
阅读详情
Berry & Associates.png

艾美捷科技代理Berry & Associates全系列修饰核苷酸等


美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

 

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry.  High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.


Berry & Associates的主要产品包括：

产品名称产品编号纯度规格
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2'-3'-DideoxyguanosinePR 3505≥95%25 mg; 100 mg
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
2',3'-DideoxyuridinePY 7278≥97%100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridinePY 7279≥97%25 mg; 100 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
2-Amino-2'-deoxyadenosinePR 3060≥97%1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosinePR 3080≥95%100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosinePR 3130≥95%100 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purinePR 3670≥95%100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purinePR 3070≥97%25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purinePR 3160≥97%100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine HemihydratePR 3180≥97%25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purinePR 3680≥97%100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosinePR 3006≥95%25 mg; 100 mg
8-Amino-2'-deoxyadenosinePR 3115≥97%10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosinePR 3120≥90%100 mg; 1 g
8-Azido-2'-deoxyadenosinePR 3125≥97%10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosinePR 3230≥95%50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosinePR 3260≥95%100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosinePR 3280≥97%100 mg; 1 g
8-Bromo-2'-deoxyadenosinePR 3290≥90%2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3320≥95%100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3340≥97%0g (discontinued);  
2'-Deoxyadenosine MonohydratePR 3445≥97%25 g; 100 g
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2-Fluoro-2'-deoxyadenosinePR 3496≥97%25 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
N6-Methyl-2'-deoxyadenosinePR 3740≥97%100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridinePRA 10012≥95%10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosinePRA 10032≥95%10 mg; 50 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosinePR 3010≥90%0Discontinued;  
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3015≥90%1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3020≥90%1 g; 10 g
5'-Azido-5'-deoxyguanosinePR 3225≥90%5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3285≥90%1 g; 10 g
8-Bromo-2'-deoxyguanosinePR 3300≥90%1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosinePR 3310≥97%500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3330≥90%250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosinePR 3335≥95%100 mg; 1 g
2'-Deoxyguanosine monohydratePR 3452≥97%10 g; 100 g
α-2'-DeoxyguanosinePR 3455≥97%10 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosinePR 3600≥97%100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosinePR 3605≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosinePR 3630≥97%100 mg; 1 g
N2-Ethyl-2'-deoxyguanosinePR 3700≥95%25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosinePR 3745≥97%10 mg; 100 mg
N1-Methyl-2'-deoxyguanosinePR 3748≥97%25 mg; 1 g
N2-Methyl-2'-deoxyguanosinePR 3750≥97%25 mg; 100 mg
O6-Methyl-2'-deoxyguanosinePR 3755≥90%5 mg; 25 mg
6-Thio-2'-deoxyguanosinePR 3845≥97%10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
2'-O-MethyladenosinePR 3734≥97%1 g;  
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridinePY 7575≥97%10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridinePY 7577≥97%10 mg; 100 mg
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosinePR 3000≥97%25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosinePR 3200≥90%50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosinePR 3210≥97%10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosinePR 3220≥97%10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosinePR 3240≥97%100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosinePR 3250≥97%100 mg; 1 g
3'-DeoxyadenosinePR 3430≥97%10 mg; 100 mg
3'-DeoxyguanosinePR 3460≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosinePR 3590≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosinePR 3690≥97%20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridinePY 7230≥97%100 mg;  
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3040≥97%1 g;  
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3045≥95%1 g;  
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purinePR 3050≥95%5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3370≥97%100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3380≥90%100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purinePR 3390≥97%0 g;  
6-Chloro-9-(β-D-ribofuranosyl)purinePR 3400≥97%5 g; 10 g
AdenosinePR 3005≥97%100 g; 1 kg
8-MethyladenosinePR 3007≥95%25 mg; 100 mg
VidarabinePR 3008≥97%1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
N1-Methyladenosine hydroiodidePR 3032≥95%100 mg; 1 g
2-MethyladenosinePR 3035≥97%10 mg; 25 mg
5'-Chloro-5'-deoxyadenosinePR 3360≥97%100 mg; 1 g
N6-MethyladenosinePR 3732≥97%100 mg; 1 g
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10000≥97%100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10005≥97%500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridinePRA 10006≥90%25 mg; 100 mg
8-AzaadenosinePRA 10007≥97%20 mg;  
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)PRA 10008≥95%10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidinePRA 10009≥95%100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosinePRA 10010≥97%100 mg; 1 g
Allopurinol ribosidePRA 10011≥97%25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosinePRA 10020≥97%100 mg; 1 g
3-Deaza-2'-deoxyadenosinePRA 10025≥97%25 mg; 100 mg
7-Deaza-2'-deoxyadenosinePRA 10030≥97%100 mg; 1 g
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
7-Deaza-2'-deoxyguanosinePRA 10040≥97%100 mg; 1 g
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
7-Deaza-2'-deoxyxanthosinePRA 10050≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosinePRA 10055≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
5-IodotubercidinPRA 10095≥90%5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10100≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10110≥97%100 mg; 1 g
SangivamycinPRA 10140≥97%10 mg; 25 mg
ToyocamycinPRA 10150≥97%10 mg; 100 mg
TriciribinePRA 10160≥97%10 mg;  
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg;  
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
dNaMFC 8110≥97%25 mg; 100 mg
9-Deaza-2'-deoxyguanosinePRA 10120≥97%10 mg; 100 mg
9-DeazaguanosinePRA 10130≥97%10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazinePYA 11000≥97%10 mg; 25 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
PyrazofurinPYA 11004≥97%10 mg;  
2'-DeoxypseudoisocytidinePYA 11005≥97%10 mg; 100 mg
2'-DeoxypseudouridinePYA 11010Purity: ≥97%25 mg; 
5'-O-(Dimethoxytrityl)-N-(dimethylamino)
methylidene-2'-deoxypseudoisocytidine		PYA 11035Purity: ≥97%50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridinePYA 11040≥97%10 mg; 100 mg
1,3-DimethylpseudouridinePYA 11050≥97%10 mg; 50 mg
N1-MethylpseudouridinePYA 11052≥95%10 mg; 50 mg
N3-MethylpseudouridinePYA 11054≥97%10 mg; 25 mg
ShowdomycinPYA 11056≥97%10 mg;  
Pseudoisocytidine hydrochloridePYA 11060≥97%10 mg; 100 mg
PseudothymidinePYA 11070≥97%10 mg; 100 mg
PseudouridinePYA 11080≥97%10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosinePR 3350≥97%10 mg;  
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-Deoxy-8,5'-cycloadenosinePR 3440≥97%10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosinePR 3500≥97%10 mg;  
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosinePR 3730≥97%10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosinePR 3800≥97%10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosinePR 3810≥97%10 mg;  
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidinePY 7054≥97%25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
5-Bromo-2'-deoxycytidinePY 7115≥97%1 g; 10 g
CytidinePY 7215≥97%50 g; 500 g
2'-DeoxycytidinePY 7216≥97%10 g; 50 g
2'-Deoxycytidine HydrochloridePY 7217≥97%5 g; 50 g
5'-Azido-2',5'-dideoxycytidinePY 7219≥97%25 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
N4-Ethyl-2'-deoxycytidinePY 7245≥97%100 mg; 250 mg
5-Methyl-2'-deoxyisocytidinePY 7255≥95%500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7270≥97%20 mg; 50 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7380≥97%50 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidinePY 7410≥97%100 mg;  
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-onePY 7540≥95%250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydratePY 7586≥95%50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidinePY 7587≥97%10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidinePY 7588≥97%50 mg; 100 mg
5-Formyl-2'-deoxycytidinePY 7589≥97%5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidinePY 7592≥95%25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium saltPY 7593≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-HydroxymethylcytidinePY 7596≥97%50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium saltPY 7598≥97%10 mg; 50 mg
5-FormylcytidinePY 7599≥97%5 mg; 10 mg
5-Iodo-2'-deoxycytidinePY 7607≥97%2 g; 10 g
5-IodocytidinePY 7609≥97%5 g;  
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Methyl-2'-deoxycytidine HydrochloridePY 7635≥97%0.25 g; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-MethylcytidinePY 7637≥97%1 g; 5 g
N4-MethylcytidinePY 7638≥97%25 mg; 100 mg
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
2-ThiocytidinePY 7721≥97%10 mg; 100 mg
2-Thio-2'-deoxycytidinePY 7723≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
8-HydroxyguanosinePR 3795≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
5-Aza-2'-deoxycytidinePY 7105≥95%25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidinePY 7106≥97%25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
Nap-dUPY 7735≥97%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
8-18O-HydroxyguanosineIOPR 3795≥95%2 mg; 5 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
N2-DimethylguanosinePR 3702≥97%10 mg; 100 mg
GuanosinePR 3703≥97%100 g; 500 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
O6-MethylguanosinePR 3757≥97%25 mg; 100 mg
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
8-BromoguanosinePR 3796≥97%0 g;  
8-BenzyloxyguanosinePR 3797≥95%100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
2'-Deoxy-4-desmethylwyosinePR 3450≥95%100 mg; 500 mg
2'-DeoxyinosinePR 3463≥97%10 g; 100 g
5'-Azido-2',5'-dideoxyinosinePR 3464≥97%5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosinePR 3480≥97%1 g;  
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosinePR 3490≥90%1 g;  
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosinePR 3660≥97%100 mg; 1 g
InosinePR 3725≥97%100 g; 500 g
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
O6-Phenyl-2'-deoxyinosinePR 3840≥97%100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3842≥97%25 mg;  
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3843≥90%25 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosinePR 3510≥90%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3520≥95%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3530≥90%100 mg; 1 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
d5SICSFC 8120≥97%25 mg; 100 mg
AICA Riboside (AICAR)MN 20001≥97%0 g (DISCONTINUED);  
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosinePR 3692≥95%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
tC NucleosidePYA 11110≥97%50 mg; 100 mg
tCnitro NucleosidePYA 11115≥95%5 mg; 25 mg
2'-DeoxynebularinePR 3470

Purity: ≥97%		100 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrolePYA 11020≥97%50 mg;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrolePYA 11030≥95%100 mg;  
ShowdomycinPYA 11056≥97%10 mg; 
Formycin APYA 11001≥97%10 mg; 
Formycin BPYA 11002≥97%10 mg; 
PseudouridinePYA 11080≥97%10 mg; 
PyrazofurinPYA 11004≥97%10 mg; 
ToyocamycinPRA 10150≥97%10 mg; 
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 
Allopurinol ribosidePRA 10011≥97%25 mg; 
5-IodotubercidinPRA 10095≥90%5 mg; 
TriciribinePRA 10160≥97%10 mg; 
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg; 
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 
5'-Amino-5'-deoxythymidinePY 7030≥97%25 mg; 50 mg
O2,5'-AnhydrothymidinePY 7060≥95%500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
5'-Azido-5'-deoxythymidinePY 7070≥97%25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7120≥97%1 g;  
3'-O-(t-Butyldimethylsilyl)thymidinePY 7130≥95%500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidinePY 7140≥97%5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidinePY 7150≥97%1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidinePY 7160≥95%100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidinePY 7200≥95%10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidinePY 7210≥95%10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7250≥97%1 g;  
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-onePY 7315≥90%1 g; 10 g
2',3'-Didehydro-3'-deoxythymidinePY 7328≥95%10 mg; 100 mg
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidinePY 7510≥97%50 mg; 100 mg
2-O-EthylthymidinePY 7561≥97%500 mg; 1 g
5'-Iodo-5'-deoxythymidinePY 7610≥97%250 mg; 1 g
5'-O-MethylthymidinePY 7680≥95%50 mg; 100 mg
2-ThiothymidinePY 7725≥95%20 mg; 100 mg
ThymidinePY 7727≥97%25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidinePY 7740≥97%5 g;  
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidinePY 7750≥97%50 mg;  
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
6-AzathymidinePYA 11058≥95%25 mg; 100 mg
NPOM-Caged-dT CEPBA 0317≥95%100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
5-Ethynyl uridine CEPBA 0353≥90%100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridinePY 7053≥97%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-onePY 7055≥97%20 mg; 100 mg
5-Bromo-2'-deoxyuridinePY 7117≥97%10 g; 25 g
5-BromouridinePY 7118≥95%5 g;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carbomethoxyvinyl)uridinePY 7172≥97%25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridinePY 7185≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridinePY 7212≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
2'-DeoxyuridinePY 7275≥97%25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridinePY 7280≥95%100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7310≥97%20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridinePY 7450≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridinePY 7465≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-Ethynyl-2'-deoxyuridinePY 7562≥97%25 mg; 100 mg
5-Ethynyl uridinePY 7563≥97%10 mg; 100 mg
5-Fluoro-2'-deoxyuridinePY 7565≥97%100 mg; 1 g
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7580≥97%25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7590≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridinePY 7604≥97%25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridinePY 7612≥95%100 mg;  
5-Iodo-2'-deoxyuridinePY 7615≥97%10 g; 25 g
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
5-IodouridinePY 7632≥95%5 g; 25 g
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
3-MethyluridinePY 7694≥97%25 mg; 100 mg
5-MethyluridinePY 7695≥97%200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridinePY 7712≥95%10 mg; 100 mg
ZebularinePY 7715≥97%10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridinePY 7720≥90%500 mg; 1 g
2-ThiouridinePY 7724≥97%25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridinePY 7730≥97%1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridinePY 7758≥97%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridinePY 7775≥97%100 mg; 1 g
UridinePY 7780≥97%100 g; 500 g
2'3'-O-Isopropylidene uridinePY 7781≥97%5 g; 25 g
5-Hydroxymethyl uridinePY 7782≥97%50 mg; 100 mg
5-MethoxyuridinePY 7783≥97%10 mg; 50 mg
6-Aza-2'-deoxyuridinePYA 11057≥95%50 mg; 100 mg

" data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
...
阅读详情
Arbor Assays.jpg

艾美捷科技特约代理Arbor Assays的全系列产品。

 

Arbor Assays公司成立于2007年，位于密歇根州的安娜堡，公司的三位主创始人均为有多年科研经验的生命和临床科学家。其宗旨是为临床使用的重要生物分子建立高质量的检测和免疫测试产品。在生物领域建立健全的免疫检测和酶活性试剂盒以定量生物分子。

 

Arbor Assays公司的主要产品包括：

DetectX® Kits

Inhibitors & Activators

AbX® Antibodies & Affinity Resins

Detection Systems

Components & Ancillary Reagents

" data-original="http://jackson.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Arbor Assays"> Arbor Assays
...
阅读详情
217218219220221222223224225226

城市分站
联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话：18327026838

传真：18327026838

邮箱：sales@amyjet.com

0.4178

Copyright © 2026 Powered by Jackson中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap